GATE: Generalized Anxiety - A Treatment Evaluation
Status: | Recruiting |
---|---|
Conditions: | Anxiety, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/17/2019 |
Start Date: | December 2013 |
End Date: | March 31, 2019 |
The purpose of this randomized study is to examine the comparative efficacy of yoga,
cognitive behavioral therapy, and stress education, a previously employed control condition,
for patients with Generalized Anxiety Disorder.
cognitive behavioral therapy, and stress education, a previously employed control condition,
for patients with Generalized Anxiety Disorder.
We are currently conducting a treatment study to reduce stress and anxiety in people with
generalized anxiety disorder (GAD). This study will not use a medication, but instead will
involve weekly stress reduction classes that use different strategies to reduce anxiety. The
study involves having a formal psychiatric interview, filling out questionnaires, ECGs,
saliva samples, a urine test for drugs of abuse, and study visits over 12 weeks. Each study
visit will take a few hours. Qualified participants will be compensated for time and travel.
generalized anxiety disorder (GAD). This study will not use a medication, but instead will
involve weekly stress reduction classes that use different strategies to reduce anxiety. The
study involves having a formal psychiatric interview, filling out questionnaires, ECGs,
saliva samples, a urine test for drugs of abuse, and study visits over 12 weeks. Each study
visit will take a few hours. Qualified participants will be compensated for time and travel.
Inclusion Criteria:
- Male or female outpatients > 18 years of age with a primary psychiatric diagnosis of
generalized anxiety disorder
- Clinical Global Impression-Severity scale (CGI-S) score of 4 or higher
- Off concurrent psychotropic medication for at least 2 weeks prior to initiation of
randomized treatment, OR stable on current medication for a minimum of 6 weeks and
willing to maintain a stable dose
- Willingness and ability to perform the yoga intervention and to comply with the
requirements of the study protocol.
- For women of childbearing potential, willingness to use a reliable form of birth
control
Exclusion Criteria:
- Patients unable to understand study procedures and participate in the informed consent
process.
- Pregnancy as assessed by pregnancy test at screen or lack of use approved methods
birth control for women of childbearing age
- Women who are planning to become pregnant
- Serious medical illness or instability for which hospitalization may be likely within
the next year
- Significant current suicidal ideation or suicidal behaviors within the past 6 months
(assessed with the Beck Depression Inventory-II [BDI-II])
- History of head trauma causing loss of consciousness, or seizure disorder resulting in
ongoing cognitive impairment
- Posttraumatic stress disorder, substance use disorder, eating disorder, or organic
mental disorder within the past 6 months
- Lifetime history of psychotic disorder, bipolar disorder, or developmental disorder
- Significant personality dysfunction likely to interfere with study participation
(assessed during the clinical interview)
- Prior experience with (more than 5 Yoga classes or CBT sessions within the last 3
years) and/or current practice of mindbody techniques (e.g., yoga, meditation,
Tai-Chi, etc) or cognitive behavioral therapy (CBT)
- Concomitant therapy for generalized anxiety disorder (GAD) (any therapy)
- Physical conditions that might cause injury from yoga (pregnancy, physical injuries
and musculoskeletal problems)
- Cognitive impairment (MOCA<21)
We found this trial at
2
sites
One Silber Way
Boston, Massachusetts 02215
Boston, Massachusetts 02215
(617) 353-2000
Principal Investigator: Stefan G Hofmann, PhD
Phone: 617-353-9610
Boston University Boston University is no small operation . With over 33,000 undergraduate and graduate...
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Naomi M Simon, MD, MSc
Phone: 617-726-1579
Click here to add this to my saved trials